Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (325)

« Back to Publications

National program for cardiovascular disease and hypertension in primary healthcare: WHO-PEN program initial scale-up in Iran (IraPEN).

Khalili D. et al, (2026), BMC Cardiovasc Disord

Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.

Zeng G. et al, (2026), Lancet, 407, 1626 - 1638

Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis.

Bidel Z. et al, (2026), Eur Heart J, 47, 1649 - 1657

Subtyping Alzheimer's disease and Parkinson's disease using longitudinal electronic health records.

Lian J. et al, (2026), Nat Aging, 6, 612 - 625

AI adoption in cardiology: regulation at a global crossroad.

Leeson P. and Rahimi K., (2026), Heart, 112, 295 - 296

First trimester maternal infections and offspring congenital heart defects: a meta-analysis.

Su H. et al, (2026), Eur Heart J, 47, 794 - 812

Beyond hypertension: quantifying the full risk landscape for heart failure in women.

Rahimi K. and Gerdts E., (2026), Heart, 112, 178 - 180

Development and validation of a parsimonious AI-based risk score for mortality in heart failure: a UK cohort study

Ahmed N. et al, (2026), European Heart Journal – Digital Health, 7

A transformer-based survival model for prediction of all-cause mortality in patients with heart failure: a multi-cohort study.

Rao S. et al, (2026), NPJ Digit Med, 9

[2025 ESC Guidelines for the management of myocarditis and pericarditis].

Schulz-Menger J. et al, (2026), G Ital Cardiol (Rome), 27, e1 - e93

Redefining endpoints in heart failure clinical trials: the emerging role of wearable technologies in contemporary trial design.

Alawoad Z. et al, (2025), Heart Fail Rev, 31

Renal denervation for hypertension management in the UK: a Delphi expert consensus.

Haworth PAJ. et al, (2025), Heart

The changing spectrum of cardiovascular diseases.

Conrad N. et al, (2025), Lancet, 406, 2040 - 2043

Advancing Risk-Based Approaches in Blood Pressure Management: Reflections on the 2025 AHA/ACC Statement.

Rahimi K. et al, (2025), Hypertension, 82, 1794 - 1798

2025 ESC Guidelines for the management of myocarditis and pericarditis.

Schulz-Menger J. et al, (2025), Eur Heart J, 46, 3952 - 4041

Load More

1
2
3
4
5
6
7
...
»